Edmond DE Rothschild Holding S.A. Sells 4,231 Shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Edmond DE Rothschild Holding S.A. trimmed its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHCFree Report) by 23.0% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 14,159 shares of the company’s stock after selling 4,231 shares during the period. Edmond DE Rothschild Holding S.A.’s holdings in GE HealthCare Technologies were worth $1,107,000 as of its most recent SEC filing.

Several other hedge funds have also recently bought and sold shares of the stock. St. James Investment Company LLC bought a new stake in shares of GE HealthCare Technologies in the 4th quarter worth about $16,397,000. Wellington Management Group LLP increased its holdings in shares of GE HealthCare Technologies by 17.2% during the fourth quarter. Wellington Management Group LLP now owns 24,341 shares of the company’s stock worth $1,903,000 after buying an additional 3,575 shares in the last quarter. Schroder Investment Management Group raised its stake in shares of GE HealthCare Technologies by 2.1% in the fourth quarter. Schroder Investment Management Group now owns 38,069 shares of the company’s stock valued at $2,992,000 after acquiring an additional 770 shares during the last quarter. Allstate Corp acquired a new position in shares of GE HealthCare Technologies in the 4th quarter worth approximately $1,081,000. Finally, DnB Asset Management AS grew its position in GE HealthCare Technologies by 8.7% during the 4th quarter. DnB Asset Management AS now owns 78,582 shares of the company’s stock worth $6,144,000 after acquiring an additional 6,257 shares during the last quarter. 82.06% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several brokerages have issued reports on GEHC. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their price objective for the stock from $85.00 to $100.00 in a research note on Tuesday, March 11th. Citigroup raised their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. Wells Fargo & Company upped their target price on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Finally, Jefferies Financial Group raised shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and raised their price target for the company from $95.00 to $103.00 in a report on Wednesday, January 8th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating, eight have issued a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $97.73.

Read Our Latest Report on GEHC

GE HealthCare Technologies Stock Performance

Shares of GE HealthCare Technologies stock opened at $79.57 on Wednesday. The firm has a fifty day moving average of $86.46 and a two-hundred day moving average of $85.76. The company has a debt-to-equity ratio of 0.88, a quick ratio of 0.83 and a current ratio of 1.04. The stock has a market capitalization of $36.39 billion, a price-to-earnings ratio of 18.38, a PEG ratio of 3.19 and a beta of 1.13. GE HealthCare Technologies Inc. has a 52 week low of $74.51 and a 52 week high of $94.80.

GE HealthCare Technologies (NASDAQ:GEHCGet Free Report) last released its earnings results on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating the consensus estimate of $1.26 by $0.19. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, equities research analysts predict that GE HealthCare Technologies Inc. will post 4.68 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, May 15th. Shareholders of record on Friday, April 25th will be paid a $0.035 dividend. This represents a $0.14 annualized dividend and a yield of 0.18%. The ex-dividend date is Friday, April 25th. GE HealthCare Technologies’s payout ratio is presently 3.23%.

GE HealthCare Technologies Profile

(Free Report)

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.

Read More

Institutional Ownership by Quarter for GE HealthCare Technologies (NASDAQ:GEHC)

Receive News & Ratings for GE HealthCare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GE HealthCare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.